Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment
- 18 August 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 111, 109125
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82071829)
- Natural Science Foundation of Liaoning Province (2021-MS-163)
This publication has 57 references indexed in Scilit:
- Cancer-Related InflammationJournal of Clinical Immunology, 2012
- Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigenHuman Vaccines & Immunotherapeutics, 2012
- Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responsesCancer Immunology, Immunotherapy, 2012
- The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse modelsJournal of Gastroenterology, 2012
- Molecular pathways and targets in cancer-related inflammationAnnals of Medicine, 2010
- Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genesInternational Journal of Cancer, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Cancer-related inflammationNature, 2008
- Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapyCancer Immunology, Immunotherapy, 2004
- Methionine Enkephalin: A New Cytokine—Human StudiesClinical Immunology and Immunopathology, 1997